SlideShare ist ein Scribd-Unternehmen logo
1 von 24
Downloaden Sie, um offline zu lesen
The leading custom service provider in antibody development and engineering
Anti-Virus Biomolecular
Discovery
To Discovery Best-in-class Biomolecular Therapies for Infective Diseases
Web: www.creative-biolabs.com
Email: info@creative-biolabs.com
Address: 203, 17 Ramsey Road, Shirley, NY 11967, USA
1. Virus of Infectious Diseases
2. Viral Pathogenesis
3. Our Platform
4. Main Technologies
CONTENTS
Virus of Infectious Diseases
Introduction to Viruses
Image From Wikimedia Commons
1 Virus of Infectious Diseases
The Baltimore Classification of viruses
Image From Wikimedia Commons
1 Virus of Infectious Diseases
Viral Life Cycle
Image From Wikipedia
1. Attachment
2. Penetration
3. Uncoating
4. Transcription
5. Synthesis
6. Assembly
7. Release
1 Virus of Infectious Diseases
The Virus that causes infectious diseases
SARS-CoV-2 HIV
Hepatitis Virus
HPAI
Rabies Virus
MERS-CoV
Zika Virus
Ebola Virus
SARS-CoV
Enterovirus 71
Dengue Virus Influenza Virus
Creative Biolabs provides antibody and peptide discovery services against the
above viruses.
1 Virus of Infectious Diseases
Viral Pathogenesis
Introduction to Viral Pathogenesis
2 Viral Pathogenesis
Loss of cell function
Kill cells
Tissue damage caused by host immune responses
Complex combination of direct damage & host
immune responses
Routes of Virus Entry
2 Viral Pathogenesis
Entry via the Respiratory Tract
Entry via the Gastrointestinal Tract
Entry via the Skin
Entry via Other Routes
Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1
2 Viral Pathogenesis
Neural spread
Hematogenous Spread
Local Spread on Epithelial Surfaces
Subepithelial Invasion and Lymphatic Spread
Mechanisms of Viral Spread and Infection
Mechanisms of Virus Shedding
2 Viral Pathogenesis
Via budding
Via apoptosis
Via exocytosis
Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1 Image From Wikipedia
Virus Transmission
2 Viral Pathogenesis
Fecal-oral Respiratory Droplets Fomites-mediated
Exchange of Bodily
Fluids or Organs
Airborne Insect Vectors
Mechanisms of Viral Injury and Disease
2 Viral Pathogenesis
Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1
Inhibition of Host-Cell Nucleic Acid
Synthesis
Inhibition of Host-Cell RNA
Transcription
Inhibition of Processing of Host-Cell
Messenger RNAs
Inhibition of Host-Cell Protein
Synthesis
Neutralizing Antibody Targets of Viral Disease
2 Viral Pathogenesis
Take AIDS as an example
CD4 binding site (CD4bs) V2 site
Membrane proximal external
region (MPER)
N332 supersite
Gp120–gp41 interface
Our Platform
Antibodies directed against membrane proteins for neutralization of virus infectivity are highly sought for
therapeutic, diagnostic, and research purposes. Creative Biolabs has developed a series of cell-based systems and
cell-free systems for virus membrane protein expression.
Membrane Protein Production and Immunization Platform
Creative Biolabs has established a broad range of expression systems including but not
limited to E. coli system, yeast system, insect system, plant system, mammalian system.
We have accumulated extensive experience in anti-virus antibody development by using
VLP immunization strategy.
VLPs Production and Immunization Platform
Creative Biolabs can offer a series of DNA immunization
strategies to develop high-affinity antibodies against the
natural conformation of the target antigen.
DNA Immunization Platform
Anti-Virus Biomolecular Discovery
3 Our Platform
Ph.D. level scientists with
extensive experience
Cost-effective and short turnaround
Board-spectrum targets
Various strategies
Diverse species available
High-throughput functional molecules
screening
Large pool of functional
antibody/peptide candidates
AntInfect™ Platform
3 Our Platform
Main Technologies
Antigen-Specific B Lymphocytes Sorting Technology
Fluorescent activated cell sorting (FACS) Laser-capture Microdissection (LCM)
4 Main Technologies
Generation of Monoclonal Antibodies
Hybridoma Technology
Abdullah Farhan ul haque Saeed, et al. Antibody Engineering for Pursuing a Healthier Future. Front Microbiol. 2017, 8,
495. doi:10.3389/fmicb.2017.00495
4 Main Technologies
Phage Display Technology
4 Main Technologies
High-Density Peptide Array
Michael Hecker, et al. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of
Multiple Sclerosis Patients. Molecular & Cellular Proteomics. 2016,15(4): 1360-1380.
4 Main Technologies
T H A N K S
Copyright © 2021 Creative Biolabs. All Rights Reserved.
https://www.creative-biolabs.com

Weitere ähnliche Inhalte

Ähnlich wie Zika Virus Antibody Discovery.pdf

Viral genome sequencing
Viral genome sequencingViral genome sequencing
Viral genome sequencingDynah Perry
 
Bioclonetics summary presentation~july 2016
Bioclonetics summary presentation~july 2016Bioclonetics summary presentation~july 2016
Bioclonetics summary presentation~july 2016Charles S. Cotropia
 
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)Stephanie Calderone
 
Vectored Vaccines.pptx
Vectored Vaccines.pptxVectored Vaccines.pptx
Vectored Vaccines.pptxVetico
 
Coronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsCoronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsKumaraguru Veerasamy
 
Seminario Biología Molecular Valery Briñez Prada.pdf
Seminario Biología Molecular Valery Briñez Prada.pdfSeminario Biología Molecular Valery Briñez Prada.pdf
Seminario Biología Molecular Valery Briñez Prada.pdfValery Leilany Briñez Prada
 
Presentation virology.pptx
Presentation virology.pptxPresentation virology.pptx
Presentation virology.pptxChinjuJoseSajith
 
2017 09-07 Global Virome Project
2017 09-07 Global Virome Project2017 09-07 Global Virome Project
2017 09-07 Global Virome ProjectThe End Within
 
Introduction to medical virology
Introduction to medical virologyIntroduction to medical virology
Introduction to medical virologyVamsi kumar
 
Lecture-1 Introduction to Virology.pptx
Lecture-1 Introduction to Virology.pptxLecture-1 Introduction to Virology.pptx
Lecture-1 Introduction to Virology.pptxssuserd846d1
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...MilliporeSigma
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Merck Life Sciences
 
General microbiology
General microbiologyGeneral microbiology
General microbiologyPeriowiki.com
 
vaccine development against COVID-19 by utilizing miRNA technique.
 vaccine development against COVID-19 by utilizing miRNA technique.    vaccine development against COVID-19 by utilizing miRNA technique.
vaccine development against COVID-19 by utilizing miRNA technique. Mehedimahidol
 
Viral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxViral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxMagAhmed
 
Microbiology - Noncellular Microbes - Louis Carlo Lim
Microbiology - Noncellular Microbes - Louis Carlo LimMicrobiology - Noncellular Microbes - Louis Carlo Lim
Microbiology - Noncellular Microbes - Louis Carlo LimLouis Lim
 

Ähnlich wie Zika Virus Antibody Discovery.pdf (20)

Viral genome sequencing
Viral genome sequencingViral genome sequencing
Viral genome sequencing
 
Bioclonetics summary presentation~july 2016
Bioclonetics summary presentation~july 2016Bioclonetics summary presentation~july 2016
Bioclonetics summary presentation~july 2016
 
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)
G. Poste presenting at Exponential Medicine 2016 Conference (San Diego)
 
Vectored Vaccines.pptx
Vectored Vaccines.pptxVectored Vaccines.pptx
Vectored Vaccines.pptx
 
Coronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic OptionsCoronavirus Pandemic Part III (B): Therapeutic Options
Coronavirus Pandemic Part III (B): Therapeutic Options
 
SARS-CoV-2 Vaccines
SARS-CoV-2 VaccinesSARS-CoV-2 Vaccines
SARS-CoV-2 Vaccines
 
Seminario Biología Molecular Valery Briñez Prada.pdf
Seminario Biología Molecular Valery Briñez Prada.pdfSeminario Biología Molecular Valery Briñez Prada.pdf
Seminario Biología Molecular Valery Briñez Prada.pdf
 
Adenovirus Services
Adenovirus ServicesAdenovirus Services
Adenovirus Services
 
Adenovirus service
Adenovirus serviceAdenovirus service
Adenovirus service
 
Presentation virology.pptx
Presentation virology.pptxPresentation virology.pptx
Presentation virology.pptx
 
2017 09-07 Global Virome Project
2017 09-07 Global Virome Project2017 09-07 Global Virome Project
2017 09-07 Global Virome Project
 
Introduction to medical virology
Introduction to medical virologyIntroduction to medical virology
Introduction to medical virology
 
Viruses-size,shape & types
Viruses-size,shape & typesViruses-size,shape & types
Viruses-size,shape & types
 
Lecture-1 Introduction to Virology.pptx
Lecture-1 Introduction to Virology.pptxLecture-1 Introduction to Virology.pptx
Lecture-1 Introduction to Virology.pptx
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
 
General microbiology
General microbiologyGeneral microbiology
General microbiology
 
vaccine development against COVID-19 by utilizing miRNA technique.
 vaccine development against COVID-19 by utilizing miRNA technique.    vaccine development against COVID-19 by utilizing miRNA technique.
vaccine development against COVID-19 by utilizing miRNA technique.
 
Viral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptxViral Cultivation and Identification Technique.pptx
Viral Cultivation and Identification Technique.pptx
 
Microbiology - Noncellular Microbes - Louis Carlo Lim
Microbiology - Noncellular Microbes - Louis Carlo LimMicrobiology - Noncellular Microbes - Louis Carlo Lim
Microbiology - Noncellular Microbes - Louis Carlo Lim
 

Mehr von Candy Swift

AI-based One-stop Antibody Discovery Platform.pdf
AI-based One-stop Antibody Discovery Platform.pdfAI-based One-stop Antibody Discovery Platform.pdf
AI-based One-stop Antibody Discovery Platform.pdfCandy Swift
 
AntInfect™ Platform at Creative Biolabs.pdf
AntInfect™ Platform at Creative Biolabs.pdfAntInfect™ Platform at Creative Biolabs.pdf
AntInfect™ Platform at Creative Biolabs.pdfCandy Swift
 
Background of Therapeutic Non-IgG Antibodies.pdf
Background of Therapeutic Non-IgG Antibodies.pdfBackground of Therapeutic Non-IgG Antibodies.pdf
Background of Therapeutic Non-IgG Antibodies.pdfCandy Swift
 
Formats of Bispecific Antibody.pdf
Formats of Bispecific Antibody.pdfFormats of Bispecific Antibody.pdf
Formats of Bispecific Antibody.pdfCandy Swift
 
Cancer Cells Surface Engineering.pdf
Cancer Cells Surface Engineering.pdfCancer Cells Surface Engineering.pdf
Cancer Cells Surface Engineering.pdfCandy Swift
 
Adenovirus Delivery System.pdf
Adenovirus Delivery System.pdfAdenovirus Delivery System.pdf
Adenovirus Delivery System.pdfCandy Swift
 
Oncolytic Herpes Simplex Virus.pdf
Oncolytic Herpes Simplex Virus.pdfOncolytic Herpes Simplex Virus.pdf
Oncolytic Herpes Simplex Virus.pdfCandy Swift
 
MiHA research deep learning.pdf
MiHA research deep learning.pdfMiHA research deep learning.pdf
MiHA research deep learning.pdfCandy Swift
 
AI-Based Antibody Screening.pdf
AI-Based Antibody Screening.pdfAI-Based Antibody Screening.pdf
AI-Based Antibody Screening.pdfCandy Swift
 
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
Introduction and Mechanism of Oncolytic Virus Therapy.pdfIntroduction and Mechanism of Oncolytic Virus Therapy.pdf
Introduction and Mechanism of Oncolytic Virus Therapy.pdfCandy Swift
 
Gene Editing ZFN, TALEN, and CRISPRCas9.pdf
Gene Editing ZFN, TALEN, and CRISPRCas9.pdfGene Editing ZFN, TALEN, and CRISPRCas9.pdf
Gene Editing ZFN, TALEN, and CRISPRCas9.pdfCandy Swift
 
AI-augmented Drug Discovery.pdf
AI-augmented Drug Discovery.pdfAI-augmented Drug Discovery.pdf
AI-augmented Drug Discovery.pdfCandy Swift
 
Display Platform for MiHC.pdf
Display Platform for MiHC.pdfDisplay Platform for MiHC.pdf
Display Platform for MiHC.pdfCandy Swift
 
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdfInfectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdfCandy Swift
 
Oncolytic Virus Biodistribution Study.pdf
Oncolytic Virus Biodistribution Study.pdfOncolytic Virus Biodistribution Study.pdf
Oncolytic Virus Biodistribution Study.pdfCandy Swift
 
Recombinant Lentivirus Products.pdf
Recombinant Lentivirus Products.pdfRecombinant Lentivirus Products.pdf
Recombinant Lentivirus Products.pdfCandy Swift
 
EV Surface Engineering Services.pdf
EV Surface Engineering Services.pdfEV Surface Engineering Services.pdf
EV Surface Engineering Services.pdfCandy Swift
 
BsAb Engineering Services.pdf
BsAb Engineering Services.pdfBsAb Engineering Services.pdf
BsAb Engineering Services.pdfCandy Swift
 
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdfDiscovery of Antibody and Peptide Targeting Escherichia.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdfCandy Swift
 

Mehr von Candy Swift (20)

AI-based One-stop Antibody Discovery Platform.pdf
AI-based One-stop Antibody Discovery Platform.pdfAI-based One-stop Antibody Discovery Platform.pdf
AI-based One-stop Antibody Discovery Platform.pdf
 
AntInfect™ Platform at Creative Biolabs.pdf
AntInfect™ Platform at Creative Biolabs.pdfAntInfect™ Platform at Creative Biolabs.pdf
AntInfect™ Platform at Creative Biolabs.pdf
 
Background of Therapeutic Non-IgG Antibodies.pdf
Background of Therapeutic Non-IgG Antibodies.pdfBackground of Therapeutic Non-IgG Antibodies.pdf
Background of Therapeutic Non-IgG Antibodies.pdf
 
Formats of Bispecific Antibody.pdf
Formats of Bispecific Antibody.pdfFormats of Bispecific Antibody.pdf
Formats of Bispecific Antibody.pdf
 
Cancer Cells Surface Engineering.pdf
Cancer Cells Surface Engineering.pdfCancer Cells Surface Engineering.pdf
Cancer Cells Surface Engineering.pdf
 
Adenovirus Delivery System.pdf
Adenovirus Delivery System.pdfAdenovirus Delivery System.pdf
Adenovirus Delivery System.pdf
 
Oncolytic Herpes Simplex Virus.pdf
Oncolytic Herpes Simplex Virus.pdfOncolytic Herpes Simplex Virus.pdf
Oncolytic Herpes Simplex Virus.pdf
 
MiHA research deep learning.pdf
MiHA research deep learning.pdfMiHA research deep learning.pdf
MiHA research deep learning.pdf
 
AI-Based Antibody Screening.pdf
AI-Based Antibody Screening.pdfAI-Based Antibody Screening.pdf
AI-Based Antibody Screening.pdf
 
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
Introduction and Mechanism of Oncolytic Virus Therapy.pdfIntroduction and Mechanism of Oncolytic Virus Therapy.pdf
Introduction and Mechanism of Oncolytic Virus Therapy.pdf
 
Gene Editing ZFN, TALEN, and CRISPRCas9.pdf
Gene Editing ZFN, TALEN, and CRISPRCas9.pdfGene Editing ZFN, TALEN, and CRISPRCas9.pdf
Gene Editing ZFN, TALEN, and CRISPRCas9.pdf
 
AI-augmented Drug Discovery.pdf
AI-augmented Drug Discovery.pdfAI-augmented Drug Discovery.pdf
AI-augmented Drug Discovery.pdf
 
Display Platform for MiHC.pdf
Display Platform for MiHC.pdfDisplay Platform for MiHC.pdf
Display Platform for MiHC.pdf
 
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdfInfectious Diseases and Anti-Virus Biomolecular Discovery.pdf
Infectious Diseases and Anti-Virus Biomolecular Discovery.pdf
 
Tandem Fab.pdf
Tandem Fab.pdfTandem Fab.pdf
Tandem Fab.pdf
 
Oncolytic Virus Biodistribution Study.pdf
Oncolytic Virus Biodistribution Study.pdfOncolytic Virus Biodistribution Study.pdf
Oncolytic Virus Biodistribution Study.pdf
 
Recombinant Lentivirus Products.pdf
Recombinant Lentivirus Products.pdfRecombinant Lentivirus Products.pdf
Recombinant Lentivirus Products.pdf
 
EV Surface Engineering Services.pdf
EV Surface Engineering Services.pdfEV Surface Engineering Services.pdf
EV Surface Engineering Services.pdf
 
BsAb Engineering Services.pdf
BsAb Engineering Services.pdfBsAb Engineering Services.pdf
BsAb Engineering Services.pdf
 
Discovery of Antibody and Peptide Targeting Escherichia.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdfDiscovery of Antibody and Peptide Targeting Escherichia.pdf
Discovery of Antibody and Peptide Targeting Escherichia.pdf
 

Kürzlich hochgeladen

Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxShubham
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书zdzoqco
 
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxLipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxRajendra Dev Bhatt
 
Mobile Health And Apps (mhealth) How to design Application for medical App.pptx
Mobile Health And Apps (mhealth) How to design Application for medical App.pptxMobile Health And Apps (mhealth) How to design Application for medical App.pptx
Mobile Health And Apps (mhealth) How to design Application for medical App.pptxMahesh Chopra
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfDharma Homoeopathy
 
Medisep insurance policy , new kerala government insurance policy for govrnm...
Medisep insurance policy , new  kerala government insurance policy for govrnm...Medisep insurance policy , new  kerala government insurance policy for govrnm...
Medisep insurance policy , new kerala government insurance policy for govrnm...LinshaLichu1
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGYDrmayuribhise
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Doveagatadrynko
 
lupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlylupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlyRitasman Baisya
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfeurohealthleaders
 
Professional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeProfessional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeEarwax Doctor
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Dr. David Greene Arizona
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxBkGupta21
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationpratiksha ghimire
 

Kürzlich hochgeladen (20)

Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptx
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
 
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptxLipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
Lipid Profile test & Cardiac Markers for MBBS, Lab. Med. and Nursing.pptx
 
Mobile Health And Apps (mhealth) How to design Application for medical App.pptx
Mobile Health And Apps (mhealth) How to design Application for medical App.pptxMobile Health And Apps (mhealth) How to design Application for medical App.pptx
Mobile Health And Apps (mhealth) How to design Application for medical App.pptx
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
 
Medisep insurance policy , new kerala government insurance policy for govrnm...
Medisep insurance policy , new  kerala government insurance policy for govrnm...Medisep insurance policy , new  kerala government insurance policy for govrnm...
Medisep insurance policy , new kerala government insurance policy for govrnm...
 
DELIRIUM psychiatric delirium is a organic mental disorder
DELIRIUM  psychiatric  delirium is a organic mental disorderDELIRIUM  psychiatric  delirium is a organic mental disorder
DELIRIUM psychiatric delirium is a organic mental disorder
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Dove
 
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdfDr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
 
Kidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani HospitalKidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani Hospital
 
lupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughlylupus quiz.pptx for knowing lupus thoroughly
lupus quiz.pptx for knowing lupus thoroughly
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Denmark's Healthcare.pdf
 
Professional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your HomeProfessional Ear Wax Cleaning Services for Your Home
Professional Ear Wax Cleaning Services for Your Home
 
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
 
unit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptxunit-3 blood product B.Pharma 3rd year .pptx
unit-3 blood product B.Pharma 3rd year .pptx
 
Incentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentationIncentive spirometry powerpoint presentation
Incentive spirometry powerpoint presentation
 

Zika Virus Antibody Discovery.pdf

  • 1. The leading custom service provider in antibody development and engineering Anti-Virus Biomolecular Discovery To Discovery Best-in-class Biomolecular Therapies for Infective Diseases Web: www.creative-biolabs.com Email: info@creative-biolabs.com Address: 203, 17 Ramsey Road, Shirley, NY 11967, USA
  • 2. 1. Virus of Infectious Diseases 2. Viral Pathogenesis 3. Our Platform 4. Main Technologies CONTENTS
  • 4. Introduction to Viruses Image From Wikimedia Commons 1 Virus of Infectious Diseases
  • 5. The Baltimore Classification of viruses Image From Wikimedia Commons 1 Virus of Infectious Diseases
  • 6. Viral Life Cycle Image From Wikipedia 1. Attachment 2. Penetration 3. Uncoating 4. Transcription 5. Synthesis 6. Assembly 7. Release 1 Virus of Infectious Diseases
  • 7. The Virus that causes infectious diseases SARS-CoV-2 HIV Hepatitis Virus HPAI Rabies Virus MERS-CoV Zika Virus Ebola Virus SARS-CoV Enterovirus 71 Dengue Virus Influenza Virus Creative Biolabs provides antibody and peptide discovery services against the above viruses. 1 Virus of Infectious Diseases
  • 9. Introduction to Viral Pathogenesis 2 Viral Pathogenesis Loss of cell function Kill cells Tissue damage caused by host immune responses Complex combination of direct damage & host immune responses
  • 10. Routes of Virus Entry 2 Viral Pathogenesis Entry via the Respiratory Tract Entry via the Gastrointestinal Tract Entry via the Skin Entry via Other Routes Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1
  • 11. 2 Viral Pathogenesis Neural spread Hematogenous Spread Local Spread on Epithelial Surfaces Subepithelial Invasion and Lymphatic Spread Mechanisms of Viral Spread and Infection
  • 12. Mechanisms of Virus Shedding 2 Viral Pathogenesis Via budding Via apoptosis Via exocytosis Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1 Image From Wikipedia
  • 13. Virus Transmission 2 Viral Pathogenesis Fecal-oral Respiratory Droplets Fomites-mediated Exchange of Bodily Fluids or Organs Airborne Insect Vectors
  • 14. Mechanisms of Viral Injury and Disease 2 Viral Pathogenesis Image From Fenner’s Veterinary Virology. DOI:10.1016/B978-0-12-375158-4.00003-1 Inhibition of Host-Cell Nucleic Acid Synthesis Inhibition of Host-Cell RNA Transcription Inhibition of Processing of Host-Cell Messenger RNAs Inhibition of Host-Cell Protein Synthesis
  • 15. Neutralizing Antibody Targets of Viral Disease 2 Viral Pathogenesis Take AIDS as an example CD4 binding site (CD4bs) V2 site Membrane proximal external region (MPER) N332 supersite Gp120–gp41 interface
  • 17. Antibodies directed against membrane proteins for neutralization of virus infectivity are highly sought for therapeutic, diagnostic, and research purposes. Creative Biolabs has developed a series of cell-based systems and cell-free systems for virus membrane protein expression. Membrane Protein Production and Immunization Platform Creative Biolabs has established a broad range of expression systems including but not limited to E. coli system, yeast system, insect system, plant system, mammalian system. We have accumulated extensive experience in anti-virus antibody development by using VLP immunization strategy. VLPs Production and Immunization Platform Creative Biolabs can offer a series of DNA immunization strategies to develop high-affinity antibodies against the natural conformation of the target antigen. DNA Immunization Platform Anti-Virus Biomolecular Discovery 3 Our Platform
  • 18. Ph.D. level scientists with extensive experience Cost-effective and short turnaround Board-spectrum targets Various strategies Diverse species available High-throughput functional molecules screening Large pool of functional antibody/peptide candidates AntInfect™ Platform 3 Our Platform
  • 20. Antigen-Specific B Lymphocytes Sorting Technology Fluorescent activated cell sorting (FACS) Laser-capture Microdissection (LCM) 4 Main Technologies
  • 21. Generation of Monoclonal Antibodies Hybridoma Technology Abdullah Farhan ul haque Saeed, et al. Antibody Engineering for Pursuing a Healthier Future. Front Microbiol. 2017, 8, 495. doi:10.3389/fmicb.2017.00495 4 Main Technologies
  • 22. Phage Display Technology 4 Main Technologies
  • 23. High-Density Peptide Array Michael Hecker, et al. High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients. Molecular & Cellular Proteomics. 2016,15(4): 1360-1380. 4 Main Technologies
  • 24. T H A N K S Copyright © 2021 Creative Biolabs. All Rights Reserved. https://www.creative-biolabs.com